Peptides and Profit
A discussion unfolds around the controversial landscape of peptides, highlighting their potential benefits and the FDA's role in regulating them. While there are genuine intentions behind safety measures, the conversation raises questions about the influence of profit margins on pharmaceutical companies and the accessibility of these compounds. The complexities of regulatory actions and the implications for public health are examined, revealing a nuanced perspective on the intersection of safety and profit.In this clip
From this podcast
Huberman Lab
Dr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity
Related Questions
What does Andrew Huberman think about peptides as discussed in the episode Dr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity and the clip Growth Hormone Insights, as well as in the episode Benefits & Risks of Peptide Therapeutics for Physical & Mental Health and the clip Understanding Therapeutic Peptides?
What does Andrew Huberman talk about regarding the safety of peptides and the black/gray markets in the episode Dr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity and the clip Peptides and Safety?
What does Andrew Huberman think about peptides in the episode Dr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity and the clip Peptides and Profit?